<DOC>
<DOCNO>EP-0621785</DOCNO> 
<TEXT>
<INVENTION-TITLE>
USE OF AQUEOUS SOLUTIONS CONTAINING PEROXOBISULPHATE IONS FOR THE TREATMENT OF MALIGNANT CELLS
</INVENTION-TITLE>
<CLASSIFICATIONS>A61M3600	A61P3500	A61P3500	A61K4100	A61M3614	A61K4100	A61K3340	A61K3340	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61M	A61P	A61P	A61K	A61M	A61K	A61K	A61K	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61M36	A61P35	A61P35	A61K41	A61M36	A61K41	A61K33	A61K33	</CLASSIFICATIONS-FOURTH>
<APPLICANTS>
<APPLICANT-NAME>
RENSCHLER ALOYS
</APPLICANT-NAME>
<APPLICANT-NAME>
RENSCHLER, ALOYS
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
RENSCHLER ALOYS
</INVENTOR-NAME>
<INVENTOR-NAME>
SCHUSTER DIETER
</INVENTOR-NAME>
<INVENTOR-NAME>
RENSCHLER, ALOYS
</INVENTOR-NAME>
<INVENTOR-NAME>
SCHUSTER, DIETER
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
Use of aqueous solutions containing peroxodisulfate ions in 
an amount of from 10
-5
 to 10
-11
 g/l for the preparation of 
medicaments for treating malignant cells of the human or 

animal body. 
The use according to claim 1, characterized in that said 
solutions contain from 10
-7
 to 10
-11
 g/l of peroxodisulfate 
ions. 
The use according to claim 1 or 2, characterized in that 
said solutions are obtained by subjecting aqueous solutions 

having a pH value of from 2 to 7 and containing anions of 
oxo acids of sulfur to actinic radiation. 
The use according to any of claims 1 to 3, characterized in 
that said aqueous solutions contain from 10
-2
 to 10
-4
 g/l of 
sulfate ions prior to being subjected to said radiation. 
The use according to any of claims 1 to 3, characterized in 
that said solutions contain stabilizers, in particular 

ethanol and/or hydrogen peroxide, in amounts of up to 15% 
by weight of ethanol and up to 1.5% by weight of hydrogen 

peroxide, based on the solution. 
The use according to any of claims 1 to 5, characterized in 
that the pH value is adjusted to a range of from 4 to 5. 
The use according to any of claims 3 to 6, characterized in 
that a plurality of, in particular at least five, irradiation  

 
vessels (7, 8, 9, 10 and 11) are provided wherein a 

certain amount of anions of oxo acids of sulfur is added to 
the first irradiation vessel (7) and high-purity water is 

supplied to each of the irradiation vessels (7, 8, 9, 10 
and 11) for performing the dilution process. 
The use according to any of claims 3 to 7, characterized in 
that said irradiation and dilution are performed under 

reduced pressure and/or an inert gas is additionally 
supplied to the first irradiation vessel (7) to generate 

turbulences and/or the liquid flowing through the vessels 
(7, 8, 9, 10 and 11) is kept at a temperature in the range 

of room temperature of 30 to 50°C, in particular 40°C. 
The use according to any of claims 3 to 8, characterized in 
that a plurality of, in particular at least five, cylindrical 

vessels (7, 8, 9, 10 and 11) having irradiation tubes 
(13, 14, 15, 16 and 17) axially arranged therein are 

provided. 
The use according to any of claims 3 to 9, characterized by 
means (1, 2, 3 and 4) for the preparation and storage of 

high-purity water. 
The use according to any of claims 3 to 10, characterized 
in that a supply vessel (19) with a solution containing 

anions of oxo acids of sulfur is connected via a valve (21) 
with the first vessel as seen in the flow direction (7). 
The use according to any of claims 3 to 11, characterized 
in that a line having a filter (41) and serving for air 

supply is connected with the first vessel (7). 
The use according to any of claims 3 to 12, characterized 
in that a line (22) is connected with the last vessel as 

seen in the flow direction (11), said line connecting the  
 

last vessel (11) with a plurality of, in particular three, 
supply vessels (23, 24, 25). 
The use according to any of claims 3 to 13, characterized 
in that sensors and/or measuring devices (36, 37, 38) are 

arranged in line (22) for monitoring the properties of the 
solution leaving the vessel (11). 
The use according to any of claims 3 to 14, characterized 
in that the supply vessels (23, 24, 25) are connected with 

line (22) via magnet valves (26, 27, 28). 
The use according to any of claims 3 to 15, characterized 
in that a vacuum pump (34) is connecte
d with the supply 
vessels (23, 24, 25). 
The use according to any of claims 3 to 16, characterized 
in that a central control unit (5) is provided which is 

connected to measuring devices (6, 35, 36, 37, 38) and 
filling level sensors (4, 31, 32, 33) via signal lines. 
The use according to any of claims 3 to 17, characterized 
in that the devices serving for the performance of the 

irradiation and dilution process (means 1 to 4 for the 
preparation of the starting material, feed pump 18, valves 

21, 26, 27, 28, 39, vacuum pump 34) are connected with the 
central control unit (5) via controlling lines. 
The use according to any of claims 3 to 18, characterized 
in that two irradiation and dilution devices are used in 

series. 
Use of aqueous solutions containing sulfate ions in an 
amount of not greater than 10
-6
 g/l for the preparation of 
medicaments for treating malignant cells of the human or 

animal body. 
</CLAIMS>
</TEXT>
</DOC>
